Gerais: Contribuir para o aprendizado oftalmológico dos alunos do 4o ano de MedicinaEspecíficos: Ensinar com maior detalhamento o exame de fundo de olho normal e patológico.
Atividades teórico-práticas Atividades práticas em ambulatório: realização de Oftalmoscopia Direta, Retinografia, Tomografia de coerência ópticaSeminário para discussão teórica e de casos clínicos.
Anatomia da Retina Fundo de Olho Normal e PatológicoOftalmoscopia RetinografiaAvaliação radiológica da retina - Tomografia de coerência óptica
1. Hogan MJ, Alvarado JA, Weddell JE. Histology of the human eye: an atlas and textbook, Philadelphia, 1971, WB Saunders, pp. 508-19.2. Weiter JJ, Delori FC, Wing GL, Kitch KA. Retinal pigment epithelial lipofuscin and melanin and choroidal melanin in human eyes. Invest Ophthalmol Vis Sci. 1986;27:145-52.3. Singer DA, Nathan DM, Fogel HA, et al. Screening for diabetic retinopathy. Ann Intern Med. 1992;116:660-71.4. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol. 1994;112:1217-28.5. Alves LA. Prevalência da retinopatia diabética na população urbana, adulta de Ribeirão Preto - São Paulo. Dissertação (Mestrado em Oftalmologia). Departamento de Oftalmologia, Otorrinoralingologia e Cabeça e Pescoço, Faculdade de Medicina de Ribeirão Preto-USP, 2004.6. Hirata CE, Fang T, Casella AMB, et al. Prevalência de retinopatia em uma população de diabéticos. Arq Bras Oftalmol. 1986;49:31-3.7. Moura CA, Fernandes ML, Jorge PT. Estudo da prevalência da retinopatia diabética no ambulatório da Universidade Federal de Uberlândia. Arq Bras Oftalmol. 1996;59:344-9.8. Souza Filho JL. Análise e estudo comparativo da prevalência da retinopatia em pacientes diabéticos com até 10 anos de doença. Dissertação (Mestrado em Oftalmologia). Departamento de Oftalmo-Otorrino, Escola Paulista de Medicina, 1986. 9. Ulson ACB, Abujamra S. Análise de 400 pacientes portadores de retinopatia. Arq Bras Oftalmol. 1986;49:9-12.10. Sander B, Larsen M, Engler C, Lund-Andersen H, Parving HH. Early changes in diabetic retinopathy: capillary loss and blood-retina barrier permeability in relation to metabolic control. Acta Ophthalmol. 1994;72:553-9.11. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology. 1984;91:1464-74.12. Chihara E, Matsuoka T, Oguar Y, Matsumar M. Retinal nerve fiber layer defect as an early manifestation of diabetic retinopathy. Ophthalmology. 1993;100:1147-51.13. Grunwald JE, DuPont J, Riva CE. Retinal haemodynamics in patients with early diabetes mellitus. Br J Ophthalmol. 1996;80:327-31.14. The Early Treatment Diabetic Retinopathy Study Research Group. Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7. Ophthalmology. 1991;98(Suppl):741-56.15. The Early Treatment Diabetic Retinopathy Study Research Group. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. ETDRS report number 2. Ophthalmology. 1987;94:761-74.16. The Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Ophthalmology. 1991;98(Suppl):823-33.17. The Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs: an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology. 1991;98(Suppl):786-806.18. Kinyoun J, Barton F, Fisher M, Hubbard L, Aiello L, Ferris F 3rd. Detection of diabetic macular edema. Ophthalmoscopy versus photography. ETDRS report number 5. 19. Ophthalmology. 1989;96:746-50; discussion 750-1.20. The Early Treatment Diabetic Retinopathy Study Research Group. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. ETDRS report number 2. Ophthalmology. 1987;94:761-74.21. The Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. ETDRS report number 1. Arch Ophthalmol. 1985;103:1796-806.22. Sperduto RD, Hiller R, Chew E, Seigel D, Blair N, Burton TC, Farber MD, Gragoudas ES, Haller J, Seddon JM, Yannuzzi LA. Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the eye disease case-control study. Ophthalmology. 1998;105:765-71.23. Bonnet S, Marechal G. Influence of arterial hypertension on diabetic retinopathy. J Mal Vasc. 1992;17:308-10.24. Julius S. Current trends in the treatment of hypertension: a mixed picture. Am J Hypertens. 1997;10:300-5.25. Keith NM, Wagener HP, Barker NW. Some differences types of essential hypertension: their cause and prognosis. Am J Med Sci. 1939:197:332-47.26. Scheie HG. Evaluation of ophthalmoscopic changes of hypertension ad arteriolar sclerosis. AMA Arch Ophthalmol. 1953;49:117-38.27. Sanborn GE, Magargal LE, Jaeger EA. Venous occlusive disease of the retina. In: Duane’s Ophthalmology 2002 CD-ROM Edition. Lippincott Williams & Wilkins, 2002. Clinical Volume 3 Capítulo 15. 28. The Eye Disease Case-Control Study Group. Risk factors for hemiretinal vein occlusion: Comparison with risk factors for central and branch retinal vein occlusion. Ophthalmology. 1998;105:765-71.29. Nenciu A, Stefan C, Tebeanu E, et al. Retinal venous occlusion and intraocular pressure. Oftalmologia 2005;49:66-70.30. Jorge R, Scott IU, Dare A, Flynn HW Jr, et al. Hemirretinal vein occlusion associated with membranous glomerulonephritis. Am J Ophthalmol. 2002;133: 415-6.31. Yaghoubi GH, Madarshahian F, Mosaui M, et al. Hiperhomocysteinaemia: risk of retinal vascular occlusion. East Mediterr Health J. 2004;10: 633-9.32. Maaroufi RM, Hamdi R, Mahjoub T, et al. Antiphospholipid syndrome and retinal vein occlusion in adults. East Mediterr Health J. 2004;10:627-32.33. Kuhli C, Koch F, Hattenbach LO, et al. Factor XII deficiency: a thrombophilic risk factor for retinal vein occlusion. Am J Ophthalmol. 2004;137:459-64.34. Arsene S, Delahousse B, Regina S, et al. Increased prevalence of factor V Leiden in patients with retinal vein occlusion and under 60 years of age. Thromb Haemost. 2005;94:101-6.35. Kanski JJ, et al. Clinical Ophthalmology – A Systematic Approach. 2003.36. Cartier A, Tadayoni R, Paques M, et al. Characterization of macular edema from various etiologies by optical coherence tomography. Am J Ophthalmol. 2005;140:200-6.37. The Branch Vein Occlusion Study Group. Argon Laser photocoagulation for macular edema and branch vein occlusion. Am J Ophthalmol. 1984;98:271-82.38. The Branch Vein Occlusion Study Group. Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion: A randomized clinical trial. Arch Ophthalmol. 1986;104:34-41.39. Green WR, Chan CC, Hutchins GM, Terry JM. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Retina 1981;1:27-55.40. The Central Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 1997; 115:486-91. Erratum in: Arch Ophthalmol 1997; 115:1275.41. The Central Vein Occlusion Study Group. Evaluation of grid pattern photocoagulation for macular edema in central retinal vein occlusion: the Central Vein Occlusion Study Group M Report. Ophthalmology 1995;102:1425-33.42. Pettersen JA, Hill MD, Demchuk AM, et al. Intra-arterial thrombolysis for retinal artery occlusion: the Calgary experience. Can J Neurol Sci. 2005;32:507-11.43. Gupta V, Sharma SC, Dogra MR, et al. Retinal and choroidal microvascular embolization with methylprednisolone. Retina 2002;22:382-6.44. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, de Jong PT, Klaver CC, Klein BE, Klein R, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol. 1995;39:367-74.
